Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma.
Bridges
E G
EG
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA.
Cheng
Y C
YC
D000998:Antiviral Agents / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D006509:Hepatitis B / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000517:prevention & control*; D009705:Nucleosides / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*
D000998:Antiviral Agents; D009705:Nucleosides; D007372:Interferons